🇺🇸 FDA
Patent

US 6207416

Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines

expired A61KA61K38/00A61K39/00

Quick answer

US patent 6207416 (Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Mar 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Mar 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K38/00, A61K39/00